*Special Analyst Alert* and 4 Companies that are Worth a Look
May 13 2015 - 7:00AM
InvestorsHub NewsWire
NEW YORK, NY April 23, 2015 – About Small Cap Traders and Four
Brief Reports
Small Cap Traders makes the connection between sophisticated
investors and high quality micro and small cap companies that are
currently undervalued. We are an issuer of reports written by
experienced financial analysts and who provide a straight forward
assessment of a profiled company. They include stocks traded in the
NYSE, NASDAQ, and OTCBB exchanges.
Our Core Values
- Small Cap Traders doesn’t push pink-sheets.
Small Cap Traders picks are always stand-and-deliver companies.
Small Cap Traders picks are always fully reporting NYSE, NASDAQ or
OTCQB companies.
Small Cap Traders works the “Street” like a pro, always providing
in-depth analyst reports.
Small Cap Traders never naps on the job with updates of profiled
companies.
No Credit Card - No Spam - No Obligation
Take the time to learn more about Small Cap Traders by reading
one the brief reports below. You will see why our members remain so
loyal.
*Special Analyst Alert*
Catasys, Inc. (OTCQB: CATS) recently received a $6 price target on
March 6th, 2015 and updated analyst coverage on May 5th, 2015 from
Chardan Capital Markets.
http://www.streetinsider.com/Analyst+Comments/Chardan+Capital+Markets+Starts+Catasys+%28CATS%29+at+Buy/10347854.html
Additional analyst coverage was issued today with a $3.25 near term
price target.
See this full report here: http://smallcapir.com/wp-content/uploads/2015/05/CATS-MM-BB-IR.pdf
A recent short report on CATS shows a squeeze trigger price of
$1.94/share. As well as a golden cross formation in the chart. If
CATS holds above the 50 DMA we could see good gains and short
covering this week.
If you would like to receive special analyst alerts faster, Text
"SmallCap" to 25827
4 Brief Reports:
Advanced Medical Isotope Corp. (OTCBB:
ADMD) is a late stage development company engaged in the
development of brachytherapy devices for therapeutic applications.
Brachytherapy uses radiation to destroy cancerous tumors by placing
a radioactive isotope inside or next to the treatment area.
Get a description of the company’s products and details of a
capital restructuring in the report you can read here: http://bit.ly/-ADMD--AnalystReport
Peregrine Pharmaceuticals, Inc. (NASDAQ:
PPHM) is a biopharmaceutical company with a pipeline of novel
drug candidates in clinical trials for the treatment and diagnosis
of cancer. The company's lead immunotherapy candidate, bavituximab,
is in Phase III development for the treatment of second-line
non-small lung cancer.
Get more details and update s about bavituximab in the report
located at this link: http://bit.ly/-PPHM--AnalystReport
Cellceutix Corp. (OTCBB:
CTIX) is a clinical stage biopharmaceutical company developing
innovative therapies with oncology, dermatology, and antimicrobial
applications.
Get a detailed report on the company’s products in the following
report including their lead candidate Kevetrin for use in the
treatment of certain cancers: http://bit.ly/---CTIX---AnalystReport
Minerco Resources, Inc. (OTCBB:
MINE) is an emerging growth company specializing in the food
and beverage industry. Its businesses include Level 5 Beverage
Company, Inc. (Level 5), Avanzar Sales & Distribution, LLC and
The Herbal Collection™. Level 5 brands include VitaminFIZZ®,
Vitamin Creamer® and Island Style™.
In the report that follows you can read about the company’s
complete exit from the energy business and get updates on its
current product lines: http://bit.ly/---MINE---AnalystReport
Forward-Looking Disclaimer
This report may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, and is subject to the Safe Harbor created by those
sections. This material contains statements about expected future
events and/or financial results that are forward-looking in nature
and subject to risks and uncertainties. Such forward- looking
statements by definition involve risks, uncertainties and other
factors, which may cause the actual results, performance or
achievements of mentioned company to be materially different from
the statements made herein.
Compliance Procedure
Content is researched, written and reviewed on a best-effort basis
by a 3rd party research analyst. However, we are only human and may
make mistakes. This report was prepared for informational purposes
only. Affiliated parties involved with producing and issuing
this report have not been compensated in any form by the profiled
company or any related party. A full disclaimer can be found
by viewing the full analyst report. We do not engage in high
frequency trading or hold any positions of profiled company. We
have not been compensated in any form for these reports.
For more information and services provided beyond this release
please use contact information provided below. If you notice any
errors or omissions, please notify us below.
A full disclaimer can be found by viewing the analyst report.
If you wish to have a company covered in more detail by our team,
or wish to learn more about our services, please contact us at
editor@smallcaptraders.com. For any urgent concerns or inquiries
please contact us.
Source: Small Cap Traders
Contact: editor@smallcaptraders.com